Mirzaten

Medicinal product

(Invented) name

Mirzaten

Active substance (s)

Mirtazapinas

Strength

30 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AX11, Mirtazapine

Marketing authorisation holder

KRKA, d.d., Novo mesto, Slovėnija

Date of authorisation

2008-02-08

Date of renewal

2013-06-20

Documents

1004 Mirzaten disperg tab RPP 2021 12 22.docx

1004 Pakuotės lapelis disperg 2021 12 22.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Mirtazapinas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18993	4838	1004838	lizdinė plokštelė	N30		Receptinis	LT/1/04/1004/004	Netiekiama	-	-	No	-	-	Download
18994	22469	1022469	lizdinė plokštelė	N60		Receptinis	LT/1/04/1004/005	Netiekiama	-	-	No	-	-
18995	22470	1022470	lizdinė plokštelė	N90		Receptinis	LT/1/04/1004/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2013-06-20	Perregistruotas
2008-02-08	Registruotas